GlassScriptPhysician profile
Walid Younis
NPI 1619018983
$14,547.71
in general payments reported to CMS, 2019-2025
52 companies · $2,855 in 2025
The $2,855 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,393 · 2020: $765 · 2021: $996 · 2022: $1,556 · 2023: $1,854 · 2024: $4,130 · 2025: $2,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,248 · Education: $1,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,248.25 |
| Education | $1,589.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,893.03 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,922.95 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Intuitive Surgical, INC. | $1,531.11 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $782.47 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Mylan Specialty L.P. | $682.71 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $654.83 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $531.20 | 2019-2025 | |
| United Therapeutics Corporation | $493.84 | 2019-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $422.90 | 2019-2023 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $356.14 | 2019-2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $335.10 | 2024-2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $313.41 | 2021-2025 | |
| Viatris Specialty LLC | $297.47 | 2025 | Yupelri |
| Insmed, INC. | $297.11 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $210.99 | 2021-2025 | Acthar |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $207.85 | 2019-2025 | Smartvest |
| Baxter Healthcare | $201.16 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Sunovion Pharmaceuticals INC. | $184.82 | 2019-2020 | |
| Ethicon INC. | $171.94 | 2020-2023 | Monarch Platform |
| Verona Pharma, INC. | $167.43 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $150.57 | 2019-2021 | |
| Amgen INC. | $129.08 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $127.14 | 2022-2025 | Zerbaxa, Recarbrio, Winrevair |
| Shionogi INC | $120.50 | 2021-2025 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $116.66 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $113.65 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.36 | 2020-2024 | Glassia |
| Philips North America LLC | $85.58 | 2019-2024 | (Ak6) Vest Therapy |
| Advanced Respiratory, INC | $83.90 | 2019-2020 | |
| Pulmonx Corporation | $79.83 | 2023-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Axsome Therapeutics, INC. | $79.83 | 2023-2025 | Sunosi |
| Inari Medical, INC. | $74.10 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Harmony Biosciences LLC | $67.06 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $66.79 | 2019-2025 | Giapreza |
| Circassia INC. | $63.85 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $57.00 | 2019 | |
| Pfizer INC. | $42.64 | 2022-2023 | |
| Octapharma USA, INC. | $41.68 | 2023 | Panzyga |
| Allergan, INC. | $31.09 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $27.46 | 2024 | Lumryz |
| Inspire Medical Systems, INC. | $26.94 | 2025 | Inspire |
| Chiesi USA, INC. | $26.18 | 2020-2021 | |
| Natus Medical Incorporated | $25.67 | 2019 | |
| Boston Scientific Corporation | $21.09 | 2022 | |
| Itamar Medical INC | $20.27 | 2024 | Watchpatone |
| Lilly USA, LLC | $19.38 | 2025 | Zepbound |
| Abbvie INC. | $18.45 | 2023 | Teflaro |
| Liquidia Technologies, INC. | $18.31 | 2025 | Yutrepia |
| Vifor Pharma, INC. | $17.88 | 2025 | Zemaira |
| Pharming Healthcare, INC. | $17.31 | 2025 | Ruconest |
| Portola Pharmaceuticals, LLC | $16.67 | 2019 | |
| 3b Medical, INC. | $16.33 | 2023-2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walid Younis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.